Jeffrey M. Jonas, See Remarks at Sage Therapeutics, Inc. (SAGE), sold 3,000 shares at $76.79 ($230K) on 2015-07-23, disclosed to the SEC on 2015-07-24.
Scheduled sale ($230k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |